Journal Of Pharmaceutical And Biomedical Analysis

Journal Title：Journal Of Pharmaceutical And Biomedical Analysis

This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.

Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.

该期刊是一个国际媒体，通过发表关于药物和生物医学分析的原创研究报告和批判性评论，满足学术、临床、政府和工业分析的需求。它涵盖了制药、生物医学和临床科学中分析的跨学科方面，包括分析方法、仪器、计算和解释的发展。提交的新应用侧重于药物纯度和稳定性研究、药代动力学、治疗监测、代谢分析；分析生物化学和法医毒理学的药物相关方面；也欢迎制药行业的质量保证。

来自成熟且选择性较差的方法领域的研究，例如 UV-VIS 分光光度法（包括导数和多波长测量）、基本电分析（电位法、极谱法和伏安法）方法、荧光法、流动注射分析等。仅在特殊情况下被接受出版，前提是与目前已知的系统相比具有独特和实质性的优势。这同样适用于任何一种方法对简单药物制剂的测定和仅基于加标样品的生物样品中药物的测定。药物纯度/稳定性研究应包含杂质/降解物的结构解析信息。

Journal Of Pharmaceutical And Biomedical Analysis创刊于1983年，由ELSEVIER出版商出版，收稿方向涵盖医学 - 分析化学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度约2.0个月，影响因子指数3.209，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。